Event Abstract Back to Event Leaveraging heat shock protein analogues to induce the expression of Interleukin 10. Smart design of emerging anti-inflammatory biomaterials Mariagemiliana Dessi1, Louise Topping1 and Matteo Santin1 1 University of Brighton, School of Pharmacy and Biomolecular Sciences, United Kingdom INTRODUCTION In tissue engineering and regenerative medicine applications, there is a compelling need of novel therapeutics for the treatment of chronic inflammation. Nowadays, the therapeutic approaches mainly help relieve the symptoms of the inflammation. The high rates of non-responders and the evidence of systemic immunosuppression have evolved in the development of selective anti-inflammatory materials. Among the family of heat shock proteins (HSPs), the heat shock protein 70 (HSP70) is the most evolutionary conserved and is widely recognized for its great ability to treat and prevent inflammatory conditions [1]. In the current scenario, the exploitation of the immunoregulatory nature of peptides derived from heat shock proteins offers a potential alternative for the treatment of inflammatory conditions. The peptide MtHSP70 derived from Mycobacterium tuberculosis HSP70 is of clinical relevance due to its immunoregulatory features. In this study, for the first time, the MtHSP70 peptide has been conjugated to a poly-L-lysine (PLL) used as coating biopolymer in tissue engineering applications. We demonstrate that the presence of MtHSP70 is able to encouraging lymphocyte to release anti-inflammatory cytokines (i.e.IL-10) causing the repolarization of macrophages, from a pro-inflammatory (M1) to an anti-inflammatory skew (M2). Aim of the study is to create an advanced and clinically-reflective coating biomaterial with anti-inflammatory cues to locally treat or prevent chronic inflammations. EXPERIMENTAL METHODS Structurally well-defined MtHSP70 mimicking peptide was synthetized through a bottom up strategy based on a multistep sequence of coupling and deprotection reactions on a solid support. The complete molecule was characterized by mass spectrometry (MS) and Fourier Transformed Infrared spectroscopy (FTIR). The peptide was conjugated by carbodiimide chemistry to poly-L-lysine at different concentrations and the functionalized materials has been analysed by FTIR to evaluate the efficacy of peptide conjugation. The cytotoxicity of the biomaterial was assessed by MTS assay and the viability of cells was evaluated by HPI test. ELISA sandwich test was performed to test the ability of lymphocyte to produce the IL-10 cytokine. Co-colture study was performed to simulate the body conditions and immunocytochemistry assessed the expression of CD206 (M2 specific surface receptor). RESULTS AND DISCUSSION Physico-chemical analysis confirmed the successful synthesis of peptide. The accurate mass measurements of MS (Fig.1) confirmed that the actual molecular weight matches the theoretical value (1611 m/z). The absorption bands of FTIR spectra revealed the characteristic elements present on the molecule backbone. As confirmed by FTIR the chemical grafting of the peptide to PLL was successful. Cell viability analysis reveals that after 24hrs in contact with functionalized substrates, both adherent and non-adherent cells are viable. ELISA test showed that lymphocytes incubated upon the functionalized material release significantly high level of IL-10. Type 1 macrophages co-cultured on PLL showed a low amount of CD206 marker and exhibited a rounded outspread cytoplasm (Fig.2). The expression of CD206 is higher on the macrophages co-coltured on the MtHSP70 functionalized coating and their morphology is evolving towards an elongated cytoskeleton (Fig.3) Figure 2. Expression of CD206 and morphology of macrophages co-coltured on PLL. Figure 3. Expression of CD206 and morphology of macrophages co-coltured on functionalized PLL. CONCLUSION In the current study, a new successful route to obtain anti-inflammatory biomaterials is demonstrated. For the first time, the heat shock mimicking peptide MtHSP70 was covalently attached to a biopolymer. The presence of peptide was able to elicit an anti-inflammatory response by stimulating the IL-10 production at levels that could induce a skewing in macrophages phenotype from M1 (inflammatory state) to M2 (anti-inflammatory state). These results are paving the way for the potential use of MtHSP70 analogues as promising molecules to functionalize biomaterials to locally treat chronic inflammatory conditions.